 Rajshekhar Kore
Concepts (146)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exosomes | 9 | 2023 | 56 | 3.240 |
Why?
| | Scavenger Receptors, Class E | 2 | 2022 | 200 | 1.190 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2024 | 198 | 1.010 |
Why?
| | alpha-Crystallin B Chain | 3 | 2015 | 14 | 1.000 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2022 | 23 | 0.890 |
Why?
| | Interleukin-1beta | 3 | 2021 | 84 | 0.740 |
Why?
| | Ventricular Remodeling | 1 | 2021 | 65 | 0.690 |
Why?
| | Myocardial Infarction | 2 | 2023 | 449 | 0.660 |
Why?
| | Myocardial Ischemia | 1 | 2021 | 130 | 0.650 |
Why?
| | Proteome | 1 | 2021 | 175 | 0.630 |
Why?
| | Myocardium | 2 | 2023 | 471 | 0.620 |
Why?
| | Fibroblasts | 1 | 2021 | 357 | 0.610 |
Why?
| | Proteomics | 1 | 2021 | 332 | 0.590 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 146 | 0.580 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 205 | 0.570 |
Why?
| | Multivesicular Bodies | 1 | 2015 | 3 | 0.480 |
Why?
| | Serine | 1 | 2015 | 37 | 0.480 |
Why?
| | Glioblastoma | 1 | 2014 | 89 | 0.400 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 390 | 0.390 |
Why?
| | Protein Structure, Quaternary | 1 | 2011 | 27 | 0.360 |
Why?
| | Blood Platelets | 2 | 2024 | 239 | 0.360 |
Why?
| | alpha-Crystallin A Chain | 1 | 2011 | 13 | 0.360 |
Why?
| | Cataract | 1 | 2011 | 46 | 0.340 |
Why?
| | Brain Neoplasms | 1 | 2014 | 302 | 0.340 |
Why?
| | Mass Spectrometry | 2 | 2021 | 294 | 0.300 |
Why?
| | Animals | 11 | 2024 | 13485 | 0.290 |
Why?
| | Methionine | 2 | 2020 | 142 | 0.280 |
Why?
| | Mice | 8 | 2023 | 5899 | 0.280 |
Why?
| | Inflammation Mediators | 2 | 2021 | 113 | 0.280 |
Why?
| | Blotting, Western | 2 | 2021 | 587 | 0.270 |
Why?
| | Platelet Count | 2 | 2024 | 78 | 0.260 |
Why?
| | Cell Line, Tumor | 5 | 2019 | 1429 | 0.250 |
Why?
| | Melanoma | 2 | 2020 | 272 | 0.250 |
Why?
| | Humans | 17 | 2024 | 52441 | 0.230 |
Why?
| | Receptors, Purinergic | 1 | 2024 | 15 | 0.210 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2023 | 51 | 0.200 |
Why?
| | Cell Movement | 2 | 2021 | 271 | 0.200 |
Why?
| | Mice, Inbred C57BL | 3 | 2023 | 1888 | 0.180 |
Why?
| | Ligands | 1 | 2022 | 205 | 0.180 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2021 | 95 | 0.180 |
Why?
| | Extracellular Matrix Proteins | 1 | 2021 | 69 | 0.170 |
Why?
| | Cell Line | 2 | 2021 | 1020 | 0.170 |
Why?
| | Cell Line, Transformed | 1 | 2021 | 74 | 0.170 |
Why?
| | Fibrosis | 1 | 2021 | 198 | 0.170 |
Why?
| | Cell Survival | 2 | 2019 | 598 | 0.170 |
Why?
| | Neural Stem Cells | 1 | 2020 | 25 | 0.160 |
Why?
| | Cell Differentiation | 2 | 2020 | 667 | 0.160 |
Why?
| | Cytoprotection | 1 | 2019 | 32 | 0.160 |
Why?
| | Spheroids, Cellular | 1 | 2019 | 26 | 0.160 |
Why?
| | Inflammation | 1 | 2024 | 649 | 0.160 |
Why?
| | Inflammasomes | 1 | 2020 | 64 | 0.150 |
Why?
| | Disease Models, Animal | 2 | 2021 | 1483 | 0.150 |
Why?
| | Rats | 3 | 2020 | 3228 | 0.150 |
Why?
| | Glioma | 2 | 2020 | 83 | 0.150 |
Why?
| | Benzeneacetamides | 1 | 2019 | 12 | 0.150 |
Why?
| | Glutaminase | 1 | 2019 | 18 | 0.150 |
Why?
| | Thiadiazoles | 1 | 2019 | 18 | 0.150 |
Why?
| | Ephrin-B2 | 1 | 2018 | 5 | 0.150 |
Why?
| | Astrocytes | 1 | 2020 | 148 | 0.150 |
Why?
| | Paracrine Communication | 1 | 2018 | 13 | 0.150 |
Why?
| | Methionine Adenosyltransferase | 1 | 2018 | 19 | 0.150 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 1004 | 0.140 |
Why?
| | Radiation Tolerance | 1 | 2019 | 78 | 0.140 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2018 | 106 | 0.140 |
Why?
| | Autophagy | 1 | 2019 | 185 | 0.140 |
Why?
| | Mutation | 2 | 2015 | 1331 | 0.140 |
Why?
| | Atherosclerosis | 1 | 2020 | 224 | 0.140 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2017 | 35 | 0.130 |
Why?
| | Silver | 1 | 2017 | 48 | 0.130 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2016 | 34 | 0.130 |
Why?
| | Gold | 1 | 2017 | 81 | 0.130 |
Why?
| | Male | 6 | 2023 | 26874 | 0.130 |
Why?
| | Dendritic Cells | 1 | 2017 | 132 | 0.130 |
Why?
| | Luminescent Proteins | 1 | 2015 | 47 | 0.120 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2015 | 68 | 0.120 |
Why?
| | rab GTP-Binding Proteins | 1 | 2015 | 23 | 0.120 |
Why?
| | Microscopy, Confocal | 1 | 2015 | 75 | 0.120 |
Why?
| | Glycosylation | 1 | 2015 | 104 | 0.120 |
Why?
| | Brain | 1 | 2023 | 1337 | 0.120 |
Why?
| | Models, Biological | 1 | 2018 | 735 | 0.120 |
Why?
| | Flow Cytometry | 1 | 2016 | 396 | 0.110 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 853 | 0.110 |
Why?
| | Apoptosis | 1 | 2019 | 1120 | 0.110 |
Why?
| | Phosphorylation | 1 | 2015 | 536 | 0.110 |
Why?
| | Lung Neoplasms | 1 | 2019 | 643 | 0.100 |
Why?
| | Heat-Shock Proteins, Small | 1 | 2011 | 2 | 0.090 |
Why?
| | Disulfides | 1 | 2011 | 17 | 0.090 |
Why?
| | Mutant Proteins | 1 | 2011 | 37 | 0.090 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 73 | 0.090 |
Why?
| | Cytokines | 1 | 2014 | 622 | 0.090 |
Why?
| | Molecular Chaperones | 1 | 2011 | 76 | 0.090 |
Why?
| | Protein Conformation | 1 | 2011 | 178 | 0.090 |
Why?
| | Primary Cell Culture | 2 | 2020 | 63 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 1216 | 0.080 |
Why?
| | Protein Binding | 1 | 2011 | 673 | 0.080 |
Why?
| | Coculture Techniques | 2 | 2020 | 142 | 0.080 |
Why?
| | Cells, Cultured | 2 | 2020 | 1583 | 0.060 |
Why?
| | Signal Transduction | 2 | 2024 | 1724 | 0.060 |
Why?
| | Purinergic Antagonists | 1 | 2024 | 8 | 0.050 |
Why?
| | Hemostasis | 1 | 2024 | 54 | 0.050 |
Why?
| | Activating Transcription Factor 6 | 1 | 2023 | 16 | 0.050 |
Why?
| | Heat-Shock Proteins | 1 | 2023 | 105 | 0.050 |
Why?
| | Immunity | 1 | 2022 | 35 | 0.050 |
Why?
| | Thrombosis | 1 | 2024 | 250 | 0.040 |
Why?
| | Elastin | 1 | 2020 | 23 | 0.040 |
Why?
| | Macrophages, Peritoneal | 1 | 2020 | 30 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2023 | 1202 | 0.040 |
Why?
| | STAT3 Transcription Factor | 1 | 2020 | 89 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2020 | 128 | 0.040 |
Why?
| | Alzheimer Disease | 1 | 2023 | 356 | 0.040 |
Why?
| | Child | 1 | 2011 | 7194 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2020 | 271 | 0.040 |
Why?
| | Diffusion Chambers, Culture | 1 | 2018 | 7 | 0.040 |
Why?
| | Culture Media, Serum-Free | 1 | 2018 | 11 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2018 | 46 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2018 | 38 | 0.040 |
Why?
| | Laminin | 1 | 2018 | 20 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2020 | 201 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2018 | 59 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 218 | 0.040 |
Why?
| | Proteoglycans | 1 | 2018 | 86 | 0.040 |
Why?
| | Drug Combinations | 1 | 2018 | 136 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2020 | 230 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2020 | 415 | 0.030 |
Why?
| | Cell Death | 1 | 2018 | 169 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 235 | 0.030 |
Why?
| | Glutamine | 1 | 2019 | 177 | 0.030 |
Why?
| | Glutathione | 1 | 2019 | 301 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2018 | 202 | 0.030 |
Why?
| | Nanotubes | 1 | 2017 | 17 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2020 | 903 | 0.030 |
Why?
| | Phagocytosis | 1 | 2017 | 54 | 0.030 |
Why?
| | Collagen | 1 | 2018 | 215 | 0.030 |
Why?
| | Neurons | 1 | 2020 | 442 | 0.030 |
Why?
| | Fluorescence | 1 | 2016 | 31 | 0.030 |
Why?
| | Photoacoustic Techniques | 1 | 2016 | 22 | 0.030 |
Why?
| | Metal Nanoparticles | 1 | 2017 | 66 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2018 | 257 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2020 | 1013 | 0.030 |
Why?
| | Mice, Nude | 1 | 2016 | 230 | 0.030 |
Why?
| | Diet | 1 | 2020 | 591 | 0.030 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2018 | 208 | 0.030 |
Why?
| | Liver Neoplasms | 1 | 2018 | 341 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2016 | 768 | 0.030 |
Why?
| | Neoplasms | 1 | 2016 | 1314 | 0.020 |
Why?
| | Female | 1 | 2019 | 28277 | 0.010 |
Why?
|
|
Kore's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|